The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparative restricted mean survival time (RMST) analysis of survival in advanced hepatocellular carcinoma (aHCC) from pivotal phase III trials: IMbrave-150, ORIENT-32, CARES-310, HIMALAYA, and CM-9DW.
 
Roberto Pazo Cid
Consulting or Advisory Role - Astellas Pharma; AstraZeneca Spain; Bristol-Myers Squibb/Celgene; Eisai Europe; Ipsen; Roche; SERVIER
Speakers' Bureau - Astellas Pharma; AstraZeneca Spain; BMS GmbH & Co. KG; SERVIER
Travel, Accommodations, Expenses - BMS GmbH & Co. KG; Lilly; Roche/Genentech
 
Carmen Blanco Abad
Speakers' Bureau - AstraZeneca; Roche
Expert Testimony - SERVIER
Travel, Accommodations, Expenses - AstraZeneca; Roche; SERVIER
 
Paula Gomila Pons
Speakers' Bureau - AstraZeneca; Roche; SERVIER
Expert Testimony - AstraZeneca; BMS GmbH & Co. KG; Roche
Travel, Accommodations, Expenses - AstraZeneca; Roche; SERVIER
 
Ana Comin Orce
No Relationships to Disclose
 
Marta Gascon Ruiz
Expert Testimony - Roche; SERVIER
 
Sara Campos Ramírez
No Relationships to Disclose
 
Pablo Gomez
No Relationships to Disclose
 
Maria Alvarez Alejandro
Consulting or Advisory Role - AstraZeneca; Roche
Speakers' Bureau - AstraZeneca; Roche; SERVIER
 
Irene Torres
No Relationships to Disclose
 
Luis Sarría
No Relationships to Disclose
 
Raquel Larrosa
No Relationships to Disclose
 
Alejandro Serrablo
No Relationships to Disclose
 
Javier Fuentes Olmo
Consulting or Advisory Role - AstraZeneca; Eisai Europe
Speakers' Bureau - AstraZeneca; Eisai Europe; Roche
Expert Testimony - AstraZeneca; Eisai Europe